Germana Bancone Selected Research

Glucosephosphate Dehydrogenase Deficiency

1/2021	G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.
1/2021	Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
11/2020	No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency.
8/2020	G6PD deficiency in malaria endemic areas of Nepal.
1/2020	Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
1/2020	Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter.
12/2019	Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
1/2019	Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion.
1/2019	The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.
1/2019	Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Germana Bancone Research Topics

Disease

32	Glucosephosphate Dehydrogenase Deficiency 01/2021 - 01/2008
31	Hemolysis 01/2021 - 01/2008
19	Vivax Malaria 10/2021 - 01/2014
18	Malaria 10/2021 - 10/2007
6	Infections 01/2019 - 12/2010
3	Neonatal Hyperbilirubinemia 01/2018 - 01/2018
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 01/2018
2	Kernicterus 01/2019 - 01/2018
2	Parasitemia 01/2019 - 10/2018
2	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2016 - 12/2014
1	Favism 01/2021
1	Jaundice (Icterus) 01/2018
1	Typhoid Fever (Typhoid) 01/2018

Drug/Important Bio-Agent (IBA)

29	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2021 - 01/2008
27	Primaquine FDA Link 01/2021 - 12/2010
10	Pharmaceutical PreparationsIBA 01/2021 - 01/2008
8	tafenoquineIBA 01/2019 - 01/2017
7	Chloroquine (Aralen)FDA LinkGeneric 10/2021 - 02/2017
7	8-aminoquinolineIBA 01/2018 - 03/2013
6	Antimalarials (Antimalarial Agents)IBA 10/2021 - 01/2014
6	EnzymesIBA 01/2021 - 01/2008
3	artenimol (dihydroartemisinin)IBA 10/2021 - 02/2017
3	piperaquineIBA 10/2021 - 02/2017
3	Dapsone FDA Link 03/2018 - 01/2008
3	Oxidants (Oxidizing Agents)IBA 01/2018 - 01/2008
2	ArtesunateIBA 10/2021 - 10/2018
2	AntigensIBA 01/2008 - 10/2007
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 10/2021
1	Mefloquine (Lariam)FDA LinkGeneric 10/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2020
1	BilirubinIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 12/2017
1	NADP (NADPH)IBA 02/2017
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2008
1	Complementary DNA (cDNA)IBA 01/2008
1	ChemokinesIBA 01/2008
1	RNA (Ribonucleic Acid)IBA 01/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2008
1	Recombinant ProteinsIBA 10/2007
1	Immunoglobulin G (IgG)IBA 10/2007

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019
1	Duration of Therapy 01/2019
1	Secondary Prevention 01/2019
1	Prenatal Care (Care, Prenatal) 01/2017
1	Blood Transfusion (Blood Transfusions) 01/2008